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The loading of peptides into the groove of MHC class I molecules prior to antigen presen-
tation is a complex process. In this issue of Cell, Park et al. (2006) show that peptide 
loading gets a helping hand from a resident ER enzyme called protein disulfide isomerase, 
a chaperone that has oxidoreductase activity.The major histocompatibility complex 
(MHC) class I molecules are designed 
to present a peptide signature derived 
from an intracellular pathogen at the 
plasma membrane, where it can be 
detected by cytotoxic T lymphocytes 
(CTLs). The intracellular processes 
that participate in bringing about this 
task include protein degradation, 
translocation, and folding. In this issue 
of Cell, Ahn and colleagues (Park 
et al., 2006) add an intriguing new 
chapter to this complex set of events. 
These authors describe how the fold-
ing of MHC class I molecules is linked 
to peptide loading by protein disulfide 
isomerase (PDI), an enzyme in the 
endoplasmic reticulum (ER). They 
also show that the US3 protein from 
human cytomegalovirus has evolved 
to destroy PDI, thereby obscuring the 
antigen-presenting function of MHC 
class I and enabling the virus to evade 
detection by T cells.
Most peptides presented by MHC 
class I are derived from cytosolic or 
nuclear proteins, which are degraded into fragments by the sequential action 
of the proteasome and cytosolic pep-
tidases. A few peptides escape com-
plete breakdown into amino acids by 
binding to chaperones or to a dedi-
cated peptide transporter called TAP 
that localizes to the ER membrane. 
The luminal domain of TAP acts as a 
binding platform for a series of chap-
erones that support the correct folding 
of MHC class I in the so-called MHC 
class I peptide-loading complex (Fig-
ure 1A) (Cresswell, 2005). Peptides are 
translocated into the ER by TAP in a 
naked form and can then follow differ-
ent fates. For example, peptides can 
be trimmed by ER aminopeptidases 
(sometimes required for generating 
correct MHC class I binding peptides) 
or can bind to ER chaperones, albeit 
with different efficiency. PDI appears 
to be the most efficient peptide-bind-
ing ER chaperone, as it binds to pep-
tides of different length and sequence 
(Spee et al., 1999). Peptides bound to 
PDI will be protected from degradation, 
which may be helpful unless trimming Cell 127, Ocis required for optimal binding to MHC 
class I (the optimal size of peptides that 
bind to MHC class I is usually 9 amino 
acids). Finally, peptides can be rap-
idly retrotranslocated into the cytosol. 
Together, these processes keep the 
concentration of free peptides low in 
the ER such that only the most recent 
peptides in the ER are available for 
MHC class I binding and do not have 
to compete with those that arrived ear-
lier (Yewdell et al., 2003). For immuno-
logically relevant peptide presentation, 
MHC class I has to select high-affin-
ity binding peptides given that they 
may need to remain at the surface of 
antigen-presenting cells like dendritic 
cells for days while they migrate from 
peripheral tissues to lymph nodes to 
initiate a T cell response. It is against 
this background that we are beginning 
to understand why the loading of MHC 
class I with high-affinity peptides in 
the ER turns out to be such a complex 
business.
The MHC class I molecule is a het-
erodimer that is stabilized by binding tober 20, 2006 ©2006 Elsevier Inc. 249
figure 1. The MHc class I Peptide-Loading Pathway
(A) Proteins from pathogens are polyubiquitinated and degraded by the proteasome. The 
degradation fragments can be further broken down to single amino acids by cytosolic pepti-
dases. Only a few peptides escape this destruction and can be translocated by the peptide 
transporter TAP into the ER lumen. Here they may bind to MHC class I molecules or chap-
erones, especially PDI. Alternatively, they are further trimmed by the aminopeptidase ERAP 
or retrotranslocated back into the cytosol by the ERAD system. Most MHC class I molecules 
acquire peptides in the peptide-loading complex (boxed) consisting of TAP; the MHC class I 
heterodimer; and the chaperones tapasin, ERp57, and calreticulin. PDI is a new component 
of this complex and controls an oxidation step that may be essential to clamp the MHC class 
I peptide-binding groove. 
(B) The selection of high-affinity peptide cargo and the oxidation of the α2 disulfide bridge in 
MHC class I molecules may be linked processes. It is possible that class I molecules with a fully 
oxidized peptide-binding groove sample incoming peptides delivered by TAP. Upon encountering 
peptide, MHC class I may close around it, resulting in a more stable interaction. Oxidoreductases 
may be important for regenerating a receptive peptide-binding groove in the (possibly frequent) 
event that low-affinity peptides dissociate from the closed/closing molecule. PDI may do this 
job alone or in concert with the other oxidoreductase in the peptide-loading complex, ERp57 
(boxed).250 Cell 127, October 20, 2006 ©2006 Elsevier Inc.to a high-affinity peptide. Only this het-
erotrimeric form is allowed to leave the 
ER for transport to the plasma mem-
brane. Peptide loading occurs with 
the help of the chaperones tapasin, 
calreticulin, and the oxidoreductase 
ERp57, which together with the MHC 
class I heterodimer form the peptide-
loading complex. Consequently, in the 
absence of any of these three chaper-
ones, a large fraction of newly synthe-
sized MHC class I molecules escape 
ER quality control and are released to 
the cell surface in a suboptimal form. 
ER chaperones thus directly or indi-
rectly support the loading of high-affin-
ity peptides onto MHC class I under 
conditions where the concentration of 
free soluble peptide is negligible.
In their new study, Park et al. (2006) 
show that the peptide-loading com-
plex is even more crowded than we 
thought. They demonstrate that a 
fourth chaperone, PDI, also partici-
pates. PDI depletion led to poor pep-
tide loading and the accumulation of 
MHC class I in which the disulfide 
bond that underpins the peptide-bind-
ing groove (in the H chain α2 domain) 
is reduced. Interestingly, the same 
situation arose when peptide supply 
to the ER was restricted in cells with 
normal PDI. These experiments pro-
vide the best evidence to date that 
peptide loading and oxidative folding 
of the MHC class I peptide-binding 
groove are intimately linked. Interest-
ingly, knockdown of the homologous 
oxidoreductase ERp57 seems to have 
less of an obvious effect on the MHC 
class I oxidation state despite its role 
in peptide loading (Garbi et al., 2006; 
Dick et al., 2002).
Why would the control of disulfide 
bridge formation in MHC class I het-
erodimers be essential for peptide 
editing? One possibility is that the 
formation of the α2 disulfide bridge 
may be critical for “setting” the pep-
tide-binding groove in a peptide-
receptive state in the peptide-loading 
complex (analogous to the opening 
of a Venus flytrap). If, as suggested 
(Elliott and Williams, 2005), peptide 
binding triggers closure of the flytrap, 
oxidoreductases may be required to 
reopen it if abortive peptide-capture 
occurs. PDI might provide the oxido-
reductase activity alone or in com-
bination with proximal ERp57 mol-
ecules. Notably, under steady-state 
conditions, the total pool of PDI in 
the ER is predominantly oxidized. In 
contrast, the oxidoreductase ERp57 
(at least in the peptide-loading com-
plex) is predominantly in the reduced 
state (Dick et al., 2002). These two 
enzymes may collaborate to reduce 
(ERp57) and oxidize (PDI) MHC 
class I in iterations of peptide bind-
ing events that are part of editing the 
peptide repertoire (Figure 1B).
Intriguingly, unlike ERp57, PDI effi-
ciently binds to peptides (Spee et al., 
1999) and thus may have a dual role 
in MHC class I loading—that is, both 
folding and peptide delivery. Park et 
al. (2006) were unable to separate 
these activities but speculate that this 
could be the case for two reasons. 
First, preventing the binding of pep-
tides to PDI by mutating its peptide-
binding site also prevented correct 
oxidation of MHC class I molecules 
(albeit to a lesser extent). Second, 
blocking peptide transport into the 
ER inhibited MHC class I oxidation. Molecular chaperones, such as 
eukaryotic heat shock protein 90 
(hsp90), promote the correct folding 
of client proteins. Biochemical stud-
ies have shown that hsp90 is an ATP-
driven machine that cooperates with 
a set of cochaperones (Riggs et al., 
2004). Although the domain architec-
hsp90: Twist a
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Molecular chaperones are cellu
tures of HtpG, the Escherichia
2006) together with the recent
(Ali et al., 2006) and an hsp90-c
insights into the hsp90 reactioPossibly, peptide supply is required 
for PDI-directed MHC class I folding. 
Thus, PDI may set the trap and deliver 
a peptide directly to the waiting jaws 
of the MHC class I peptide-binding 
groove. It is equally possible that pep-
tides are just cofactors for PDI activ-
ity or that the peptide-binding site of 
PDI represents a “foldase” active site. 
This remains to be established.
Finally, Park et al. (2006) provide 
an evolutionary argument for the rel-
evance of PDI activity in the antigen-
presentation pathway. In the “struggle 
for survival,” human cytomegalovirus 
targets various steps in the MHC 
class I antigen-processing pathway 
as a stealth strategy to avoid immune 
detection. In prior work, Park et al. 
(2004) showed that one of these pro-
teins, US3, binds to TAP, MHC class 
I heavy chain, and tapasin, thereby 
inactivating the peptide-editing func-
tion of the latter. They now show that 
US3 also targets PDI for degrada-
tion, thus reducing the capacity of 
infected cells to present antigens. 
PDI degradation also affects other 
folding processes, as “only” 15% of Cell 127, Oc
ture of hsp90 is conserved between 
E. coli and man, none of the cochap-
erones that aid in hsp90 function in 
the eukaryotic cell have been found in 
prokaryotes. In this issue, Shiau et al. 
(2006) present the crystal structure 
of the archetypal hsp90 chaperone 
in E. coli, HtpG. The new structures 
nd fold
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lar machines that facilitate prot
 coli homolog of hsp90, report
ly published structures of an h
lient protein complex (Vaughan
n cycle.available PDI is busy inducing MHC 
class molecules to fold. As Park and 
colleagues elegantly demonstrate, 
viral interest in PDI as a target for 
degradation confirms the importance 
of chaperone proteins for successful 
antigen presentation under normal 
conditions.
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reveal the dramatic conformational 
changes in HtpG that accompany its 
ATPase cycle.
The hsp90 protein is modular 
with three well-defined domains, an 
N-terminal ATP binding domain, a 
middle domain that completes the 
ATPase site and binds to client pro-
ein folding. The crystal struc-
ed in this issue (Shiau et al., 
sp90-cochaperone complex 
 et al., 2006), reveal exciting 
